1. Home
  2. SURG vs RNXT Comparison

SURG vs RNXT Comparison

Compare SURG & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SURG
  • RNXT
  • Stock Information
  • Founded
  • SURG 2006
  • RNXT 2012
  • Country
  • SURG United States
  • RNXT United States
  • Employees
  • SURG N/A
  • RNXT N/A
  • Industry
  • SURG Advertising
  • RNXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SURG Consumer Discretionary
  • RNXT Health Care
  • Exchange
  • SURG Nasdaq
  • RNXT Nasdaq
  • Market Cap
  • SURG 31.3M
  • RNXT 31.6M
  • IPO Year
  • SURG N/A
  • RNXT 2021
  • Fundamental
  • Price
  • SURG $1.39
  • RNXT $1.46
  • Analyst Decision
  • SURG Buy
  • RNXT Strong Buy
  • Analyst Count
  • SURG 2
  • RNXT 2
  • Target Price
  • SURG $8.50
  • RNXT $6.50
  • AVG Volume (30 Days)
  • SURG 124.8K
  • RNXT 108.8K
  • Earning Date
  • SURG 03-11-2025
  • RNXT 03-31-2025
  • Dividend Yield
  • SURG N/A
  • RNXT N/A
  • EPS Growth
  • SURG N/A
  • RNXT N/A
  • EPS
  • SURG N/A
  • RNXT N/A
  • Revenue
  • SURG $83,602,653.00
  • RNXT N/A
  • Revenue This Year
  • SURG N/A
  • RNXT N/A
  • Revenue Next Year
  • SURG $59.69
  • RNXT N/A
  • P/E Ratio
  • SURG N/A
  • RNXT N/A
  • Revenue Growth
  • SURG N/A
  • RNXT N/A
  • 52 Week Low
  • SURG $1.33
  • RNXT $0.77
  • 52 Week High
  • SURG $9.23
  • RNXT $1.86
  • Technical
  • Relative Strength Index (RSI)
  • SURG 31.02
  • RNXT 58.08
  • Support Level
  • SURG $1.33
  • RNXT $1.32
  • Resistance Level
  • SURG $1.45
  • RNXT $1.40
  • Average True Range (ATR)
  • SURG 0.08
  • RNXT 0.11
  • MACD
  • SURG -0.01
  • RNXT 0.00
  • Stochastic Oscillator
  • SURG 16.67
  • RNXT 39.47

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: